Estradiol Valerate/Levonorgestrel

戊酸雌二醇/左炔诺孕酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEstradiol Valerate/Levonorgestrel
Drug Alias NameNuvelleSH-386
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsEndocrine System Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritorySpain
Original Approved Date1997/01/01
Country/TerritorySpain
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsEndocrine System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeG03CA53
Related LinksN/A